ADVERTISEMENT

 

Press Releases

 

15

Nov

2022

What states have the worst influenza activity right now?

Author: Anonym

According to CDC’s influenza tracking map, 7 states and Washington, DC, are in the highest category for influenza activity. These states—Alabama, Georgia, Mississippi, North Carolina, Tennessee, South Carolina, and Virginia—have all been categorized as having “very high” influenza activity.

Comments (0)
Number of views (22152)
Article rating: 4.7
Read more

Categories: APhA News

Tags: APhA News

11

Nov

2022

Over 1 million Americans with diabetes rationed insulin, says new report

A new report published in the Annals of Internal Medicine found that an estimated 1.3 million U.S. adults with diabetes rationed their insulin in the past year, representing 16.5% of those who use prescribed insulin.

Comments (0)
Number of views (15154)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

3

Nov

2022

New interactive map promotes access to pharmacy services

Author: Anonym

Dima M. Qato, PharmD, MPH, PhD, regards pharmacy access as a human rights issue. Qato, an associate professor at the School of Pharmacy at the University of Southern California (USC) and a senior fellow at the USC Leonard D. Schaeffer Center for Health Policy & Economics, developed an interactive, nationwide mapping tool that reveals the presence of “pharmacy deserts” around the country.

Comments (0)
Number of views (16736)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

3

Nov

2022

One in ten older adults in the U.S. has dementia, study suggests

Author: Anonym

A study published in JAMA Neurology estimated that in the United States, 1 in 10 adults over the age of 65 has dementia and 1 in 5 has cognitive difficulties.

Comments (0)
Number of views (21480)
Article rating: 5.0
Read more

Categories: APhA News

Tags: APhA News

3

Nov

2022

FDA releases draft guidance to spur development of CDI drugs

Author: Anonym

New guidance released by FDA provides advice for sponsors on developing drugs for treating Clostridioides difficile infection (CDI). The draft guidance discusses how to design trials and trial populations, efficacy and safety endpoints, nonclinical studies, and pharmacokinetic studies.

Comments (0)
Number of views (14937)
Article rating: No rating
Read more

Categories: APhA News

Tags: APhA News

RSS
First2829303133353637Last
Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT